DU PONT TO MARKET BOEHRINGER DRUG IN US

DU PONT TO MARKET BOEHRINGER DRUG IN US

E.I. du Pont de Nemours & Co. has secured from Boehringer Ingleheim Pharmaceuticals Inc. exclusive U